© EQS Newswire
02.10.2024
EUZ
LISTED
XETR
Abspaltung der Pentixapharm AG im Handelsregister eingetragen
News Preview
Berlin, 2.10.2024. Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) informiert, dass der in der ordentlichen Hauptversammlung vom 26.6.2024 beschlossene Abspaltungsbeschluss am heutigen Tag in das Handelsregister des Amtsgerichts Charlottenburg (Berlin) eingetragen wurde. Mit der Eintragung in das Handelsregister der Eckert & Ziegler SE ......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.10.2024
EUZ
LISTED
XETR
Spin-off of Pentixapharm AG Registered with the Commercial Register
News Preview
Berlin, 2 October 2024. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) announces that the spin-off resolution approved at the Annual General Meeting on 26 June 2024 was entered in the commercial register of the Charlottenburg (Berlin) District Court today. With the entry in the commercial register of Eckert & Ziegler SE, the spin-off of Pe......
Themefolio
Profiler
Peergroup
© PR Newswire
02.10.2024
IMMNOV
LISTED
STO
Immunovia completes analytical validation of its next-generation pancreatic cancer test
News Preview
LUND, Sweden, Oct. 2, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announces that the company has completed the analytical validation of its next-generation test designed to detect early-stage pancreatic cancer. The validation demonstrated excellent results across a comprehensive set...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
02.10.2024
IMMNOV
LISTED
STO
Immunovia completes analytical validation of its next-generation pancreatic cancer test
News Preview
LUND, Sweden, Oct. 2, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announces that the company has completed the analytical validation of its next-generation test designed to detect early-stage pancreatic cancer. The validation demonstrated excellent results across a comprehensive set...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© EQS Newswire
01.10.2024
FYB
LISTED
XETR
First Berlin Equity Research GmbH: Formycon AG | Rating: Buy
News Preview
Original-Research: Formycon AG - from First Berlin Equity Research GmbH
01.10.2024 / 17:05 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude cer......
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2024
INDV
LISTED
NASDAQ
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Indivior PLC (“Indivior” or “the Company”) (NASDAQ: INDV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2024
IBAB
LISTED
EURONEXT
IBA SA – NOTIFICATION TRANSPARENCE
News Preview
...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2024
HLN
LISTED
LSE
Haleon Announces Leadership Transition in Canada: Rupa Bahri to Depart, Christine Jakovcic Appointed as New General Manager
News Preview
MISSISSAUGA, ON, Oct. 1, 2024 /CNW/ - Haleon, a global leader in consumer health, today announced the appointment of Christine Jakovcic as General Manager, Haleon Canada. This appointment follows Rupa Bahri stepping down after a distinguished 13-year career with the company to pursue other interests. Over the past six years, Rupa's leadership has...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2024
HELP
LISTED
NASDAQ
Cybin Expands Clinical Team to Support CYB003 Phase 3 Program
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced the appointment of senior clinical team leaders, Dr. Mirza Rahman as Senior Vice Presiden...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2024
CRW
LISTED
AIMX
The Craneware Group Announces Strategic Partnership with Microsoft, Featuring Three Innovative Solutions on the Microsoft Azure Marketplace
News Preview
DEERFIELD BEACH, Fla., Oct. 1, 2024 /PRNewswire/ -- The Craneware Group™, a leader in healthcare financial performance and 340B management, is excited to announce a strategic partnership with Microsoft through agreements related to the Microsoft Azure cloud platform....
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2024
AMRX
LISTED
NASDAQ
Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, and Metsera, Inc. (“Metsera”), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced that they have entered into a collaboration agreement to enable the eff...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2024
ORY
LISTED
BME
ORYZON receives minutes from End-of-Phase II meeting with the FDA on the PORTICO-2 Phase III vafidemstat trial in Borderline Personality Disorder
News Preview
MADRID and CAMBRIDGE, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today the receipt of the official meeting minutes from a recent End-of-Phase II meeting fo...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
30.09.2024
QGEN
LISTED
NYSE
QIAGEN führt digitales PCR-System QIAcuityDx für klinische Tests in der Onkologie ein
News Preview
Erweitert das Anwendungsspektrum für die erfolgreiche digitale PCR-Plattform QIAcuity durch Einführung in den klinischen Bereich in Nordamerika und der EU // Bietet absolute Quantifizierung, die für die präzise Überwachung seltener Targets in der klinischen Diagnostik unerlässlich ist // Steigert Laboreffizienz und reduziert Kosten mit einem All-in...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2024
INDV
LISTED
NASDAQ
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Indivior PLC (INDV)
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming October 1, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Indivior PLC (“Indivior” or the “Company”) (NASDAQ: INDV) securities between February 22, 2024 and July 8, 2024, inclusive (the “Class Period”).
If you are a shar...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.09.2024
GXI
LISTED
XETR
Adjustment of growth guidance for 2024 and 2025
News Preview
Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025
Düsseldorf, September 30, 2024 – Gerresheimer AG (ISIN: DE000A0LD6E6) is adjusting its growth guidance for 2024 and 2025 due to the significantly slower than expected market recovery 2024 and lower anticipated market growth in 2025 in the vial market. The guidance is also affected ......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.09.2024
GXI
LISTED
XETR
Anpassung der Wachstumsprognose für 2024 und 2025
News Preview
Gerresheimer AG: Anpassung der Wachstumsprognose für 2024 und 2025
Düsseldorf, 30. September 2024 – Gerresheimer AG (ISIN: DE000A0LD6E6) passt seine Wachstumsprognose für 2024 und 2025 an. Hintergrund ist die deutlich langsamer als erwartete Markterholung 2024 und das niedriger als erwartete Marktwachstum 2025 im Markt für Injektionsfläschchen. D......
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2024
ZEAL
LISTED
CPH
Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024
News Preview
Company announcement – No. 46 / 2024...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2024
IMMNOV
LISTED
STO
Change in number of shares and votes in Immunovia AB (publ)
News Preview
LUND, Sweden, Sept. 30, 2024 /PRNewswire/ -- During September 2024, the registered number of shares and votes in Immunovia AB (publ) ("Immunovia") has increased due to the rights issue of units resolved by the board of directors on 20 May 2024 and approved by the annual general meeting on 19 June 2024, as well as the directed issue of units to un...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2024
IMMNOV
LISTED
STO
Change in number of shares and votes in Immunovia AB (publ)
News Preview
LUND, Sweden, Sept. 30, 2024 /PRNewswire/ -- During September 2024, the registered number of shares and votes in Immunovia AB (publ) ("Immunovia") has increased due to the rights issue of units resolved by the board of directors on 20 May 2024 and approved by the annual general meeting on 19 June 2024, as well as the directed issue of units to un...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2024
SOBI
LISTED
STO
New number of shares and votes in Sobi
News Preview
STOCKHOLM, Sept. 30, 2024 /PRNewswire/ -- As per 30 September 2024, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) amounts to 356,000,049 shares. All shares are common shares. The total number of votes is 356,000,049. The increase in the number of shares and votes results from issues of 1,641,103 class C shares. The clas...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2024
SOBI
LISTED
STO
New number of shares and votes in Sobi
News Preview
STOCKHOLM, Sept. 30, 2024 /PRNewswire/ -- As per 30 September 2024, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) amounts to 356,000,049 shares. All shares are common shares. The total number of votes is 356,000,049. The increase in the number of shares and votes results from issues of 1,641,103 class C shares. The clas...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.09.2024
FYB
LISTED
XETR
Formycon and Fresenius Kabi receive FDA approval for FYB202/ OtulfiTM (ustekinumab-aauz)
News Preview
Press Release // September 30, 2024
Formycon and Fresenius Kabi receive FDA approval for FYB202/ OtulfiTM (ustekinumab-aauz)
OtulfiTMreceived FDA approval for both subcutaneous and intravenous formulations, to treat the same conditions as Stelara®
Approval represents the third successful FDA approval for a Formycon biosimilar, two of them in ......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.09.2024
FYB
LISTED
XETR
Formycon und Fresenius Kabi erhalten FDA-Zulassung für FYB202/ OtulfiTM (Ustekinumab-aauz)
News Preview
Pressemitteilung // 30. September 2024
Formycon und Fresenius Kabi erhalten FDA-Zulassung für FYB202/ OtulfiTM (Ustekinumab-aauz)
Die FDA genehmigt FYB202/OtulfiTM sowohl für subkutane als auch für intravenöse Formulierungen und für alle Stelara®-Indikationen
Diese Zulassung ist die dritte erfolgreiche FDA-Zulassung für ein Biosimilar von Fo......
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2024
ORNBV
LISTED
HEL
Orion’s near-term climate targets approved by the Science Based Targets initiative
News Preview
ORION CORPORATIONPRESS RELEASE30 SEPTEMBER 2024 at 10.00 a.m. EEST...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2024
INDV
LISTED
NASDAQ
INDV Deadline: Rosen Law Firm Urges Indivior PLC (INDV) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers and acquirers of securities of Indivior PLC (NASDAQ: INDV) between February 22, 2024 and July 8, 2024, both dates inclusive (the “Class Period”). Indivior PLC is a pharmaceutical company.
For more information, submi...
Themefolio
Profiler
Peergroup
© BusinessWire
27.09.2024
BLUE
LISTED
NASDAQ
bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing
News Preview
bluebird bio, Inc. (Nasdaq: BLUE) today announced that it has completed the filing of its Form 10-Q for the quarter ended June 30, 2024 (the “Q2 2024 Form 10-Q”) with the Securities and Exchange Commission (“SEC”).
With the completion of this filing, the Company is now current in its SEC periodic reporting obligations.
About bluebird bio, Inc....
Themefolio
Profiler
Peergroup
© EQS Newswire
27.09.2024
FYB
LISTED
XETR
FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
News Preview
Disclosure of inside information according to Article 17 of the Regulation (EU) No 596/2014
FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Planegg-Martinsried, Germany, September 27, 2024 – Formycon AG (FSE: FYB, "Formycon“) announces that the U.S. Food and Drug Administration (“FDA”) today approved FYB202/OtulfiTM......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.09.2024
FYB
LISTED
XETR
FDA erteilt Zulassung für Stelara® - Biosimilar FYB202/Otulfi™ (Ustekinumab-aauz)
News Preview
Veröffentlichung von Insiderinformationen nach Artikel 17 der Verordnung (EU) Nr. 596/2014
FDA erteilt Zulassung für Stelara®- Biosimilar FYB202/Otulfi™ (Ustekinumab-aauz)
Planegg-Martinsried, Deutschland, 27. September 2024 – Die Formycon AG (FWB: FYB, “Formycon“) gibt bekannt, dass die U.S. Food and Drug Administration („FDA“) heute die Zulass......
Themefolio
Profiler
Peergroup
© Globe Newswire
27.09.2024
LEGN
LISTED
NASDAQ
CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line
News Preview
SOMERSET, N.J., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced late-breaking three-year follow-up data from the Phase 3 CARTITUDE-4 study that shows a single infusion of CARVYKTI® (ciltacabtagene autoleucel) significantly extended overall survival (OS...
Themefolio
Profiler
Peergroup
© PR Newswire
27.09.2024
RAY B
LISTED
STO
RaySearch's CEO sells shares - remains a long-term shareholder
News Preview
STOCKHOLM, Sept. 27, 2024 /PRNewswire/ -- RaySearch's founder and CEO, Johan Löf, has sold 150,000 Class B shares in RaySearch Laboratories AB (publ) on September 24, 2024. Johan Löf remains a long-term shareholder and after the transaction owns 5,443,084 Class A shares and 68,393 Class B shares, corresponding to 16.1 percent of the total number...
Themefolio
Profiler
Peergroup
© BusinessWire
27.09.2024
ICLR
LISTED
NASDAQ
ICON plc Schedules Third Quarter 2024 Earnings Conference Call
News Preview
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the third quarter 2024 after the market closes on Wednesday, October 23, 2024. The company will hold a conference call and webcast to discuss its financial results and performance on Th...
Themefolio
Profiler
Peergroup
© PR Newswire
27.09.2024
RAY B
LISTED
STO
Latest innovations in RayStation, RayCare, and RayIntelligence to be presented at ASTRO 2024
News Preview
STOCKHOLM, Sept. 27, 2024 /PRNewswire/ -- RaySearch will be exhibiting its latest software innovations at ASTRO in Washington, D.C., September 29 – October 1. Participants can book demonstrations of RayStation®* treatment planning system, RayCare®* oncology information system, and the cloud-based oncology analytics system RayIntelligence® in RayS...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.09.2024
FYB
LISTED
XETR
Formycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory diseases
News Preview
Press Release // September 27, 2024Formycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory diseases
FYB202/Otulfi® received European Commission (EC) approval for both subcutaneous and intravenous formulations, providing a high-quality treatment option for European......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.09.2024
FYB
LISTED
XETR
Formycon und Fresenius Kabi erhalten Zulassung der Europäischen Kommission für FYB202/Otulfi® (Ustekinumab) zur Behandlung schwerwiegender inflammatorischer Erkrankungen
News Preview
Pressemitteilung // 27. September 2024
Formycon und Fresenius Kabi erhalten Zulassung der Europäischen Kommission für FYB202/Otulfi® (Ustekinumab) zur Behandlung schwerwiegender inflammatorischer Erkrankungen
FYB202/Otulfi® hat die Zulassung der Europäischen Kommission (EC) für subkutane und für intravenöse Formulierungen erhalten und bietet euro......
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2024
GMAB
LISTED
CPH
Grant of Restricted Stock Units and Warrants to Employees in Genmab
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2024
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update
News Preview
OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2024
AFX
LISTED
XETR
ZEISS reinvents lens extraction with the first hand-held ultrasound-free lens removal device, available in the U.S.
News Preview
The ZEISS MICOR 700 uses the ZEISS NULEX (non-ultrasonic lens extraction) procedure to help surgeons broaden their intraocular working space, minimizing risk to surrounding eye structures and increasing operating room efficiency.
DUBLIN, Calif. and JENA, Germany, Sept. 26, 2024 /CNW/ -- ZEISS Medical Technology today announced the broad U.S. dist...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2024
BAVA
LISTED
CPH
Bavarian Nordic Upgrades its Financial Guidance for 2024
News Preview
COPENHAGEN, Denmark, September 26, 2024 – Bavarian Nordic A/S (OMX: BAVA) upgrades its financial guidance for 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2024
BAVA
LISTED
CPH
Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines
News Preview
COPENHAGEN, Denmark, September 26, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with UNICEF for the supply of 1 million doses of the MVA-BN® mpox vaccine for countries in Africa impacted by the mpox outbreak....
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2024
TEM
LISTED
NASDAQ
Tempus Announces Expansion of Collaboration with Takeda to Leverage Multimodal Real-World Datasets and Biological Model Systems in Oncology Research and Development
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announces an expansion to its collaboration with Takeda (TSE:4502/NYSE:TAK) that takes a data-first approach to research and development, with the aim of enhancing Takeda’s oncology research and development efforts....
Themefolio
Profiler
Peergroup
© EQS Newswire
26.09.2024
1SXP
LISTED
XETR
SCHOTT Pharma, Gerresheimer und Stevanato Group schließen strategische 'Allianz für RTU'
News Preview
SCHOTT Pharma, Gerresheimer und Stevanato Group schließen strategische "Allianz für RTU"
Marktakzeptanz von „Ready-to-Use“-Primärverpackungen schreitet voran
Verbesserung der Betriebseffizienz in pharmazeutischen Herstellungsprozessen
Erhöhung der Patientensicherheit durch hochwertige sterile Primärverpackungen
SCHOTT Pharma AG & Co. KGaA (M......
Themefolio
Profiler
Peergroup
© EQS Newswire
26.09.2024
1SXP
LISTED
XETR
SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU”
News Preview
SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU”
Market advances adoption of ready-to-use containers
Improved operational efficiency in pharmaceutical manufacturing processes
Increased patient safety with high-quality sterile primary packaging
SCHOTT Pharma AG & Co. KGaA (MDAX: 1SXP), a pioneer ......
Themefolio
Profiler
Peergroup
© EQS Newswire
26.09.2024
GXI
LISTED
XETR
Gerresheimer, Stevanato Group und SCHOTT Pharma schließen strategische 'Alliance for RTU'
News Preview
Gerresheimer, Stevanato Group und SCHOTT Pharma schließen strategische "Alliance for RTU"
Marktakzeptanz von „Ready-to-Use“-Primärverpackungen schreitet voran
Verbesserung der Betriebseffizienz in pharmazeutischen Herstellungsprozessen
Erhöhung der Patientensicherheit durch hochwertige sterile Primärverpackungen
Düsseldorf, 26. September 2024. ......
Themefolio
Profiler
Peergroup
© EQS Newswire
26.09.2024
GXI
LISTED
XETR
Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry “Alliance for RTU”
News Preview
Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry “Alliance for RTU”
Market advances adoption of ready-to-use containers
Improved operational efficiency in pharmaceutical manufacturing processes
Increased patient safety with high-quality sterile primary packaging
Düsseldorf, September 26, 2024. Gerresheimer AG (MDAX: G......
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2024
MURA
LISTED
NASDAQ
Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress
News Preview
Key data readouts for the company’s late-stage, potentially registrational trials of nemvaleukin are expected in late Q1/early Q2 2025 for platinum-resistant ovarian cancer and Q2 2025 for mucosal melanoma...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2024
ORNBV
LISTED
HEL
Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster
News Preview
ORION CORPORATION INVESTOR NEWS 26 SEPTEMBER 2024 at 11.00 EEST...
Themefolio
Profiler
Peergroup
© EQS Newswire
26.09.2024
EVT
LISTED
XETR
Evotec und Novo Nordisk gehen Technologiepartnerschaft für Zelltherapien der nächsten Generation ein
News Preview
Novo Nordisk stellt finanzielle Mittel für die Technologieentwicklung bei Evotec zur Verfügung, um die klinische und kommerzielle Herstellung von stammzellbasierten Therapien zu unterstützen
Hamburg, 26. September 2024:
Evotec SE (Frankfurter Wertpapierbörse: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute bekannt, da......
Themefolio
Profiler
Peergroup
© EQS Newswire
26.09.2024
EVT
LISTED
XETR
Evotec and Novo Nordisk enter into technology development partnership to support next-generation cell therapies
News Preview
Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial manufacturing of stem cell-based therapies
Hamburg, Germany, 26 September 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that Evotec has entered a techn......
Themefolio
Profiler
Peergroup
© ACCESS Newswire
26.09.2024
CLBX
LISTED
AIMX
Angle PLC Announces 100th Publication Supporting Parsortix System Use
News Preview
GUILDFORD, SURREY / ACCESSWIRE / September 26, 2024 / Whole Genomic Sequencing and machine learning identifies key cancer genes associated with DNA proliferation and repairANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
26.09.2024
EVT
LISTED
XETR
Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies
News Preview
Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial manufacturing of stem cell-based therapies HAMBURG, GERMANY / ACCESSWIRE / September 26, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) announced today that Evotec has entered a technolog...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
26.09.2024
CLBX
LISTED
AIMX
Angle PLC Announces Half-year Report
News Preview
Interim Results for the six months ended 30 June 2024LARGE PHARMA STRATEGY IMPLEMENTED SUCCESSFULLYThree Large Pharma contracts secured each with substantial revenue potentialStrategic decision post period end to focus resources on pharma services GUILDFORD, SURREY / ACCESSWIRE / September 26, 2024 / ANGLE plc ("ANGLE" or "the Compan...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2024
QGEN
LISTED
NYSE
PreAnalytiX, ein Joint Venture von QIAGEN und BD, bringt neuartige Lösung für urinbasierte Flüssigbiopsie auf den Markt
News Preview
Das PAXgene Urine Liquid Biopsy Set mit Sammelbehälter und Nukleinsäure-Stabilisierungsröhrchen ermöglicht eine nicht-invasive Probenentnahme und direkte Stabilisierung zellfreier DNA aus Urin // QIAGEN vermarktetet das Set mit dem ersten verifizierten, standardisierten und vollständigen präanalytischen Workflow von der Urinsammlung über die Stabil...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2024
LIVN
LISTED
NASDAQ
LivaNova to Announce Third-Quarter 2024 Results
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its third-quarter 2024 results on Wednesday, October 30, 2024 at 12 p.m. London time (8 a.m. Eastern Time). The Company will release its third-quarter 2024 results prior to the call.
A live audiocast will be accessible at www.livanova....
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2024
CYRX
LISTED
NASDAQ
SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices
News Preview
NASHVILLE, Tenn. and RANCHO CORDOVA, Calif., Sept. 25, 2024 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences industry, and SK pharmteco, a global contract development and manufacturing organization, today announced a strategic collaboration to provide fully integrated logi...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2024
TFX
LISTED
NYSE
Teleflex™ Chooses o9’s AI-Powered Platform for End-to-End Integrated Business Planning and Supply Chain Management
News Preview
o9, a leading enterprise AI software platform provider for transforming planning and decision-making, today announced that Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has selected o9 to help enhance its end-to-end integrated business planning and supply chain management capabilities. This partnership inclu...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2024
COLO B
LISTED
CPH
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
News Preview
Please see enclosed pdf....
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2024
ALM
LISTED
BME
New Data Show Almirall´s EBGLYSS® (Lebrikizumab) Provided Sustained Disease Control for up to Three Years in More Than 80% of Adults and Adolescents With Moderate-to-severe Atopic Dermatitis
News Preview
More than 80 percent of adults and adolescents with moderate-to-severe atopic dermatitis who responded to lebrikizumab treatment at Week 16 in the ADvocate 1 and 2 monotherapy trials and continued treatment for up to three years experienced sustained skin clearance with monthly maintenance dosing. Almirall S.A. (BME: ALM) announced these new long-...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2024
ORNBV
LISTED
HEL
Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology
News Preview
ORION CORPORATION PRESS RELEASE 25 SEPTEMBER 2024 at 15.00 EEST ...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2024
ERF
LISTED
EURONEXT
Eurofins CDMO Alphora Inc. Announces Construction of GMP Biologics Manufacturing Facility
News Preview
Eurofins CDMO Alphora Inc. announces the construction of a new GMP Biologics manufacturing facility in Mississauga, Ontario, to manufacture monoclonal Antibodies (mAbs) and protein therapies for clinical and commercial applications.
This investment has been complemented with substantial support from the Federal Government of Canada, and a contrib...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2024
HELP
LISTED
NASDAQ
Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Amir Inamdar, Cybin’s Chief Medical Officer, will participate in a panel disc...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
